Table 1.
Baseline Characteristics According to History of Gout Diagnosis*
| Characteristics | Women
|
Men
|
||||
|---|---|---|---|---|---|---|
| No Gout (n=19,450) | Gout (n=3,890) | P† | No Gout (n=28,760) | Gout (n=5,752) | P† | |
| Age, mean ± SD years | 75.0 ± 6.8 | 75.0 ± 6.8 | 0.99 | 73.3 ± 6.4 | 73.9 ± 6.4 | 0.991 |
| Co-morbid medical conditions | ||||||
| Hypertension | 9,220 (47.4 ) | 2,552 (65.6 ) | 0.001 | 10,944 (38.1) | 3,206 (55.7) | 0.001 |
| COPD | 3,811 (19.6) | 1,007 (25.6) | 0.001 | 5,898 (20.5) | 1,387 (24.1) | 0.001 |
| Diabetes | 2,197 (11.3) | 719 (18.5) | 0.001 | 4,035 (14.0) | 884 (15.4) | 0.008 |
| Hyperlipidemia | 2,140 (11.0) | 571 (14.7) | 0.001 | 2,652 (9.2) | 741 (12.9) | 0.001 |
| Charlson comorbidity score, mean ± SD | 1.1 ± 1.7 | 1.4 ± 1.8 | 0.001 | 1.3 ± 1.8 | 1.4 ± 1.8 | 0.31 |
| Prescription medication use | ||||||
| NSAID | 10,055 (51.7) | 3,168 (81.4) | 0.001 | 12,835 (44.6) | 4,604 (80.0) | 0.001 |
| Diuretic | 3,910 (20.1) | 1,312 (33.7) | 0.001 | 3,494 (12.2) | 1,239 (21.5) | 0.001 |
| Statin | 1,830 (9.4) | 508 (13.1) | 0.001 | 1,914 (6.7) | 512 (8.9) | 0.001 |
| Aspirin | 1,418 (7.3) | 326 (8.4) | 0.018 | 1,619 (5.6) | 351 (6.1) | 0.158 |
| Glucocorticoid | 1,364 (7.0) | 368 (9.5) | 0.001 | 1,637 (5.7) | 422 (7.3) | 0.001 |
| Anticoagulant | 628 (3.2) | 227 (5.8) | 0.001 | 1,225 (4.3) | 368 (6.4) | 0.001 |
| Hormone replacement therapy | 952 (4.9) | 153 (3.9) | 0.010 | -- | -- | -- |
*
Values are the number (percentage) unless otherwise indicated;
†
P-value by chi-square or t-test.; COPD = chronic obstructive pulmonary disease, NSAID = non-steroidal anti-inflammatory drug.